Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Duplicated Gene Found for Highly Prevalent Facial Anomaly

By LabMedica International staff writers
Posted on 21 May 2014
The genetic cause of a facial disorder known as hemifacial microsomia (HFM) or Goldenhar syndrome, the second-most common facial anomaly after cleft lip and palate, has been discovered.

While most HFM cases are sporadic, approximately 2% to 10% of cases are familial and occur in more than one generation, supporting the contribution of genetic risk factors which can be identified by whole-exome sequencing.

A team of scientists led by those at the Whitehead Institute for Biomedical Research (Cambridge, MA, USA) conducted a systematic analysis to identify an etiological variant of HFM and to increase the power of the investigation they focused on a large family with multiple affected individuals. More...
The team studied the genomes of a five-year-old female member of the family, along with those of her mother, grandmother, and male cousin, who all exhibited traits of HFM. Later, the genetic information from the grandmother's Russian cousin, who resides in the Philadelphia area, was recruited to the study.

DNA was derived from collected whole blood with the investigators searching for a point mutation, but the five of the study participants held no such mutation in common. Next they looked for sections of the genome that are duplicated. All had an extra copy of one 1.3 megabase pair section of chromosome 14 and duplications this large are frequently detrimental.

Within this large piece of DNA, they identified eight candidate genes that could cause the type of HFM running in this family. They then used two algorithms to compare the molecular signatures of these eight genes to other genes known to be responsible for various facial malformations with features similar to HFM. The gene orthodenticle homeobox 2 (OTX2) emerged above the seven other candidates as the cause and it codes for a transcription factor.

The authors concluded that determining the causative gene for HFM can promote stratification of cases based on the molecular pathology, guide clinical care, offer reproductive alternatives to families that carry an OTX2 duplication, and facilitate definitive diagnosis, which is currently inadequate for HFM. Importantly, implicating OTX2 in this disorder can improve understanding of the basic molecular processes that underlie normal and pathological craniofacial development. They suggest clinicians be aware of the possibility of increased risk for medulloblastoma in HFM cases with OTX2 duplications. The study was published on May 9, 2014, in the journal Public Library of Science ONE.

Related Links:

Whitehead Institute for Biomedical Research



New
Gold Member
Collection and Transport System
PurSafe Plus®
Portable Electronic Pipette
Mini 96
Hemodynamic System Monitor
OptoMonitor
6 Part Hematology Analyzer with RET + IPF
Mispa HX 88
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Hematology

view channel
Image: New evidence shows viscoelastic testing can improve assessment of blood clotting during postpartum hemorrhage (Photo courtesy of 123RF)

Viscoelastic Testing Could Improve Treatment of Maternal Hemorrhage

Postpartum hemorrhage, severe bleeding after childbirth, remains one of the leading causes of maternal mortality worldwide, yet many of these deaths are preventable. Standard care can be hindered by delays... Read more

Immunology

view channel
Image: The CloneSeq-SV approach can allow researchers to study how cells within high-grade serous ovarian cancer change over time (Photo courtesy of MSK)

Blood Test Tracks Treatment Resistance in High-Grade Serous Ovarian Cancer

High-grade serous ovarian cancer (HGSOC) is often diagnosed at an advanced stage because it spreads microscopically throughout the abdomen, and although initial surgery and chemotherapy can work, most... Read more

Industry

view channel
Image: Private equity firms Blackstone and TPG have joined forces to acquire Hologic in a major healthcare deal (Photo courtesy of Hologic)

Hologic to be Acquired by Blackstone and TPG

Hologic (Marlborough, MA, USA) has entered into a definitive agreement to be acquired by funds managed by Blackstone (New York, NY, USA) and TPG (San Francisco, CA, USA) in a transaction valued at up to... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.